Search

Your search keyword '"Eppes, Catherine"' showing total 181 results
Start Over Author "Eppes, Catherine" Publication Year Range Last 10 years
181 results on '"Eppes, Catherine"'

22. Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study

Author

Delaney, Meghan, Wikman, Agneta, van de Watering, Leo, Schonewille, Henk, Verdoes, Jennie P., Emery, Stephen P., Murphy, Michael F., Staves, Julie, Flach, Susanne, Arnold, Donald M., Kaufman, Richard M., Ziman, Alyssa, Harm, Sarah K., Fung, Mark, Eppes, Catherine S., Dunbar, Nancy M., Buser, Andreas, Meyer, Erin, Savoia, Helen, Abeysinghe, Padmakumari, Heddle, Nancy, Tinmouth, Alan, Traore, Aicha N., and Yazer, Mark H.

Published
2017
Full Text
View/download PDF

25. Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (<scp>COVID</scp>‐19) infection

Author

Chen, Dunjin, Yang, Huixia, Cao, Yun, Cheng, Weiwei, Duan, Tao, Fan, Cuifang, Fan, Shangrong, Feng, Ling, Gao, Yuanmei, He, Fang, He, Jing, Hu, Yali, Jiang, Yi, Li, Yimin, Li, Jiafu, Li, Xiaotian, Li, Xuelan, Lin, Kangguang, Liu, Caixia, Liu, Juntao, Liu, Xinghui, Pan, Xingfei, Pang, Qiumei, Pu, Meihua, Qi, Hongbo, Shi, Chunyan, Sun, Yu, Sun, Jingxia, Wang, Xietong, Wang, Yichun, Wang, Zilian, Wang, Zhijian, Wang, Cheng, Wu, Suqiu, Xin, Hong, Yan, Jianying, Zhao, Yangyu, Zheng, Jun, Zhou, Yihua, Zou, Li, Zeng, Yingchun, Zhang, Yuanzhen, Guan, Xiaoming, Eppes, Catherine S., Fox, Karin, and Belfort, Michael A.

Subjects
China, medicine.medical_specialty, Consensus, Coronavirus disease 2019 (COVID-19), Pneumonia, Viral, MEDLINE, medicine.disease_cause, Betacoronavirus, 03 medical and health sciences, 0302 clinical medicine, Pregnancy, Risk Factors, Obstetrics and Gynaecology, Pandemic, medicine, Humans, 030212 general & internal medicine, Pregnancy Complications, Infectious, Intensive care medicine, Pandemics, Coronavirus, Infection Control, 030219 obstetrics & reproductive medicine, SARS-CoV-2, business.industry, Transmission (medicine), Vaginal delivery, Infant, Newborn, COVID-19, Obstetrics and Gynecology, Expert consensus, General Medicine, Delivery, Obstetric, medicine.disease, Corrigenda, Infectious Disease Transmission, Vertical, Female, Coronavirus Infections, business
Abstract

OBJECTIVE: To provide clinical management guidelines for novel coronavirus (COVID-19) in pregnancy. METHODS: On February 5, 2020, a multidisciplinary teleconference comprising Chinese physicians and researchers was held and medical management strategies of COVID-19 infection in pregnancy were discussed. RESULTS: Ten key recommendations were provided for the management of COVID-19 infections in pregnancy. CONCLUSION: Currently, there is no clear evidence regarding optimal delivery timing, the safety of vaginal delivery, or whether cesarean delivery prevents vertical transmission at the time of delivery; therefore, route of delivery and delivery timing should be individualized based on obstetrical indications and maternal-fetal status.

Published
2020

36. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team

Author

Erfani, Hadi, primary, Fox, Karin A., additional, Clark, Steven L., additional, Rac, Martha, additional, Rocky Hui, Shiu-Ki, additional, Rezaei, Atefeh, additional, Aalipour, Soroush, additional, Shamshirsaz, Amir A., additional, Nassr, Ahmed A., additional, Salmanian, Bahram, additional, Stewart, Kelsey A., additional, Kravitz, Elizabeth S., additional, Eppes, Catherine, additional, Coburn, Michael, additional, Espinoza, Jimmy, additional, Teruya, Jun, additional, Belfort, Michael A., additional, and Shamshirsaz, Alireza A., additional

Published
2019
Full Text
View/download PDF

37. Clinical Importance of Placental Testing among Suspected Cases of Congenital Zika Syndrome

Author

Seferovic, Maxim D., primary, Turley, Michelle, additional, Valentine, Gregory C., additional, Rac, Martha, additional, Castro, Eumenia C. C., additional, Major, Angela M., additional, Sanchez, Brianna, additional, Eppes, Catherine, additional, Sanz-Cortes, Magdalena, additional, Dunn, James, additional, Kautz, Tiffany F., additional, Versalovic, James, additional, Muldrew, Kenneth L., additional, Stout, Timothy, additional, Belfort, Michael A., additional, Demmler-Harrison, Gail, additional, and Aagaard, Kjersti M., additional

Published
2019
Full Text
View/download PDF

42. Outcomes associated with trial of labor after cesarean in women with one versus two prior cesarean deliveries after a change in clinical practice guidelines in an academic hospital.

Author

Davidson, Christina, Bellows, Patricia, Shah, Utsavi, Hawley, Lauren, Drexler, Kathleen, Gandhi, Manisha, Eppes, Catherine, and Sangi-Haghpeykar, Haleh

Subjects
INDUCED labor (Obstetrics), CESAREAN section, VAGINAL birth after cesarean, SHOULDER dystocia, UTERINE rupture, RESEARCH, RESEARCH methodology, RETROSPECTIVE studies, EVALUATION research, MEDICAL cooperation, MEDICAL protocols, PREGNANCY outcomes, COMPARATIVE studies, LABOR (Obstetrics)
Abstract

Objective: In 2010, the American College of Obstetricians & Gynecologists (ACOG) published a new clinical practice guideline on trial of labor after cesarean (TOLAC) that was considered less restrictive. It allowed for offering TOLAC to women with two prior cesarean deliveries, even without a prior vaginal delivery, and for labor induction. As a result, our hospital, a public tertiary care academic center, updated our TOLAC practice guideline to reflect ACOG's new recommendations. We thus aim to evaluate maternal and neonatal outcomes for women undergoing TOLAC with 1 versus 2 prior cesareans, with and without a prior vaginal delivery, following these clinical practice changes at our hospital.Study design: This was a secondary analysis of a 2-year retrospective cohort following implementation of a hospital guideline in women undergoing TOLAC with a live, cephalic, singleton without lethal anomaly ≥24 0/7 weeks and 1 or 2 prior cesarean deliveries. Maternal and neonatal outcomes in women with one prior cesarean were compared to women with two prior cesareans. The primary outcome was composite maternal morbidity (uterine rupture, uterine dehiscence, hysterectomy, transfusion, postpartum venous thromboembolism, delivery/surgical injury, chorioamnionitis or endometritis, shoulder dystocia, death). Secondary outcomes included neonatal morbidity. The analysis was performed in SAS; p < .05 was considered significant.Results: Seven hundred women with one prior cesarean and 73 women with two prior cesareans underwent TOLAC after the 2011 guideline implementation. Post guideline maternal demographics, labor length, comorbid conditions, simplified Bishop score, and induced labor were similar between groups. Composite maternal morbidity was similar between groups (18.3 versus 23.3%, p = .30 for women with 1 versus 2 prior cesarean deliveries, respectively). The same was true when comparing women with 1 versus 2 prior cesareans who had never had a prior vaginal delivery (25.5 versus 33.3%, p = .28 for 1 versus 2 prior cesarean deliveries, respectively). There were no differences in neonatal outcomes. Vaginal birth after cesarean (VBAC) success rates were similar between groups (78.9% in women with 1 prior cesarean versus 74.0% in women with 2 prior cesareans, p=.33), even when only analyzing women without a prior vaginal delivery (69.4% in women with 1 prior cesarean versus 71.4% in women with 2 prior cesareans, p = .78).Conclusion: Adoption of ACOG's TOLAC practice changes, specifically offering TOLAC to women with two prior cesareans even without a prior vaginal delivery, and offering induction of labor regardless of cervical favorability, may increase VBAC rates without increasing maternal or neonatal morbidity from TOLAC. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

43. Maternal comorbidity index and severe maternal morbidity during delivery hospitalizations in Texas, 2011‐2014.

Author

Salahuddin, Meliha, Mandell, Dorothy J., Lakey, David L., Ramsey, Patrick S., Eppes, Catherine S., Davidson, Christina M., Ortique, Carla F., and Patel, Divya A.

Subjects
ALCOHOLISM, ASTHMA, CESAREAN section, CHILDBIRTH, CONFIDENCE intervals, CONGENITAL heart disease, DIABETES, HIV infections, HOSPITAL care, HYPERTENSION, MULTIVARIATE analysis, NOSOLOGY, PREECLAMPSIA, PREGNANCY complications, RESEARCH funding, SICKLE cell anemia, SYSTEMIC lupus erythematosus, T-test (Statistics), VULVAR diseases, COMORBIDITY, LOGISTIC regression analysis, SECONDARY analysis, SOCIOECONOMIC factors, DISEASE prevalence, CROSS-sectional method, RECEIVER operating characteristic curves, DESCRIPTIVE statistics, ODDS ratio
Abstract

Background: Severe maternal morbidity (SMM) prevalence was 194.0 per 10 000 deliveries in Texas in 2015. Chronic, behavioral, and pregnancy‐induced conditions, as captured by a maternal comorbidity index, increase the risk for delivery‐related morbidity and mortality. The objective of the study was to examine the association between maternal comorbidity index and SMM among delivery hospitalizations in Texas. Methods: Delivery‐related hospitalizations among Texan women aged 15‐49 years were identified using the 2011‐2014 Texas all‐payer inpatient hospitalization public use data files (n = 1 434 441). The primary outcome of interest was SMM, based on the Alliance for Innovation on Maternal Health's coding scheme. The exposure of interest was a maternal comorbidity index. Multivariable logistic regression model was used to examine the association between maternal comorbidity index and SMM. Results: SMM prevalence remained consistent between 2011 and 2014 (196.0‐197.0 per 10 000 deliveries, P >.05; n = 1 434 441). Nearly 40% of delivery‐related hospitalizations had a maternal comorbidity index of at least 1, and the proportion of deliveries in the highest risk category of comorbidity index (≥5) increased by 12.0% from 2011 to 2014. SMM prevalence was highest among the youngest and oldest age groups. With each unit increase in maternal comorbidity index, the odds of SMM increase was 1.43 (95% CI 1.42‐1.43). Conclusions: Maternal comorbidity index is associated with SMM; however, the low predictive power of the model suggests that other, unmeasured factors may influence SMM in Texas. These findings highlight a need to understand broader contextual factors (practitioner, facility, systems of care, and community) that may be associated with SMM to reduce maternal morbidity and mortality in Texas. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

48. 932: Words Matter: Measured Impact of Political Rhetoric on Timely & Regular Access of Prenatal Care Among Latino & Hispanic Women in Houston, Texas from 2011-2017

Author

Levitt, Ryan, primary, Aagaard, Joshua, additional, Chu, Derrick, additional, Dildy, Gary, additional, Clark, Steven, additional, Mastrobattista, Joan, additional, Ashton, David, additional, Rac, Martha, additional, Eppes, Catherine, additional, Gandhi, Manisha, additional, Belfort, Michael, additional, Corrigan, Robert, additional, and Aagaard, Kjersti, additional

Published
2018
Full Text
View/download PDF

50. Placenta previa without morbidly adherent placenta: comparison of characteristics and outcomes between planned and emergent deliveries in a tertiary center

Author

Erfani, Hadi, primary, Kassir, Elias, additional, Fox, Karin A., additional, Clark, Steven L., additional, Karbasian, Niloofar, additional, Salmanian, Bahram, additional, Shamshirsaz, Amir A., additional, Espinoza, Jimmy, additional, Nassr, Ahmed A., additional, Eppes, Catherine S., additional, Belfort, Michael A., additional, and Shamshirsaz, Alireza A., additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results